Long-term effects of analgesics in a population of elderly nursing home residents with persistent nonmalignant pain.

Gerontology Division and Harvard Medical School Division on Aging, Beth Israel Deaconess Medical Center, 110 Francis Street, LMOB 1A, Boston, MA, USA.
The Journals of Gerontology Series A Biological Sciences and Medical Sciences (Impact Factor: 4.98). 03/2006; 61(2):165-9. DOI: 10.1093/gerona/61.2.165
Source: PubMed

ABSTRACT Little is known about the long-term effects of analgesics on functional status and well-being of nursing home residents with chronic pain.
Using the Minimum Data Set, we performed a longitudinal study of nursing home residents (n = 10,372) with persistent pain. Using propensity score adjustment techniques, we compared the effect of different analgesics on changes in physical, cognitive, emotional, and social functioning, and examined rates of adverse events over a 6-month period.
There was no change in the analgesic class for at least 6 months for 35.4% of residents, including 40% who received no analgesics during this time. Use of nonopioids was 37.9%, short-acting opioids was 18.9%, and long-acting opioids was 3.3%. We found improvement in functional status (adjusted hazard ratio = 1.85; 95% confidence interval [CI], 1.05-3.23) and social engagement (adjusted hazard ratio = 1.58; 95%, CI, 0.99-2.50) with long-acting opioids compared with short-acting opioids. There were no changes in cognitive status or mood status, or increased risk of depression with use of any analgesics, including opioids. There was a trend toward a lower risk of falls with use of any analgesics (adjusted odds ratio = 0.87; 95% CI, 0.70-1.06). Rates of other adverse events (i.e., constipation, delirium, dehydration, pneumonia) were not found to be higher among chronic opioid users compared to those taking no analgesics or nonopioids.
The use of long-acting opioids may be a relatively safe option in the management of persistent nonmalignant pain in the nursing home population, yielding benefits in functional status and social engagement.

  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Low-trauma hip fracture in old age leads to impairment, increased need of care and mortality. Rehabilitation should start in the department for traumatology and accompany the patient through different settings until the pretraumatic status is reached. Besides the surgical procedure and the medical management of an aged person with complex disease and polypharmacy, the multidisciplinary rehabilitation process is an important factor for regaining ability for self-care and autonomous decisions. Pain management supports the process. The ideal setting is not clear yet. Besides established rehabilitation facilities for elderly people, including the departments for 'Akutgeriatrie/Remobilisation', the 'Outreach Geriatric Remobilisation' project offers new perspectives. It was designed to remobilise patients with multimorbidity in their own homes.
    Wiener Medizinische Wochenschrift 10/2013; 163(19-20). DOI:10.1007/s10354-013-0241-1
  • [Show abstract] [Hide abstract]
    ABSTRACT: Zusammenfassung Über die Charakteristika von Patienten mit Rückenschmerzen, die Opioide erhalten, ist wenig bekannt. Anhand von Routinedaten einer gesetzlichen Krankenkasse (Deutsche Angestellten-Krankenkasse) werden Verordnungsmuster bei Rückenschmerzpatienten und der Zusammenhang zwischen Opioid- und Antiemetikaverordnung sowie zwischen Opioidtherapie und Arbeitsunfähigkeit (AU) untersucht. Mittels typischer Diagnosemuster wurden drei Rückenschmerztypen identifiziert: (andere) spezifische Rückenschmerzen (46,0%), Schmerzen bei Bandscheibenerkrankungen (30,5%) sowie nichtspezifische Rückenschmerzen (23,5%). Der Anteil von Versicherten mit kontinuierlicher Opioidtherapie lag zwischen 24,3 und 48,8%. Die Verordnung von Antiemetika war assoziiert mit einer höheren Chance für eine kontinuierliche Opioidtherapie (Odds Ratio [OR] 1,93; 95%-Konfidenzintervall [KI]: 1,79–2,08). Die Chance für eine kontinuierliche Opioidtherapie ist außerdem bei Rückenschmerzen durch Bandscheibenerkrankungen und bei (anderen) spezifischen Rückenschmerzen höher (OR 1,62 bzw. 1,76; 95%-KI 1,56–1,69 bzw. 1,69–1,83). Eine kontinuierliche Opioidtherapie erwies sich als ein Faktor, der die Chance auf eine geringere Zahl von AU-Tagen im weiteren Verlauf erhöhte (Incidence Rate Ratio [IRR] 0,76; 95%-KI 0,70–0,84). In geeigneten prospektiven Studien sollte geprüft werden, ob sich die hier gefundenen Assoziationen untermauern lassen.
    Der Schmerz 04/2011; 25(2):174-183. DOI:10.1007/s00482-011-1026-3 · 1.50 Impact Factor
  • [Show abstract] [Hide abstract]
    ABSTRACT: In elderly patients, persistent pain negatively impacts quality of life. An interdisciplinary approach to pain management and emphasis on quality improvement will help to achieve better therapeutic outcomes. Managing pain in the geriatric population is challenging because of age-related changes in pain perception, cognition, pharmacokinetics, and drug effects. Improvement and maintenance of physical and emotional function is the goal. Pharmacotherapy should be initiated conservatively and titrated to effective doses with minimal adverse effects. Milder pain should be treated with non-opioid analgesics with a progression toward opioids and/or adjuvant medications as the pain intensifies. Acetaminophen, nonsteroidal anti-inflammatory drugs (NSAIDs), opioids, and adjuvant medications represent most of the analgesic agents used in pain management. Knowing the underlying mechanism of pain will help guide pharmacologic therapy. The patient should be monitored initially, with every dose change, and periodically to assess efficacy and severity of adverse effects.
    Journal of Pharmacy Practice 02/2007; 20(1):49-63. DOI:10.1177/0897190007304369